The Würzburg Platelet Group
We are dedicated to basic, translational and clinical research in the field of platelet and megakaryocyte biology in health and disease. We adopt a highly interdisciplinary approach relying on the combination of mouse genetics, disease models, advanced imaging techniques, systems biology, and clinical research expertise. Our mission is a comprehensive understanding of the platelet-megakaryocyte system in thrombotic, thrombo-inflammatory and malignant disease states with the aim to ultimately develop novel treatment concepts for these disorders.
To address major questions in this emerging research area and to tackle new challenges with outstanding expertise, we are engaged in multiple local, national, and international collaborations.
A new highly effective thrombosis inhibitor is in sight: Würzburg scientists present promising inhibitor EMA601 for efficient prevention and treatment of arterial thrombosis and inflammatory reactions without increased bleeding risk. Learn more!
ERC Advanced Grant: 2.5 Million Euros for Bernhard Nieswandt. Learn more!
In this lab, we believe
We believe diverse viewpoints are essential to tackling challenging problems with creative and novel solutions – our lab strives to provide an excellent and welcoming environment to improve both our research and our community.
Science is real
Love is love
All lives matter
Diversity fuels innovation
Feminism is for everyone
Platelets are cool!
Immigrants are welcome
